EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

A randomized controlled trial of metastasis-directed therapy for oligometastases in breast cancer: OLIGAMI trial (JCOG2110)

Keita Sasaki iD, Toshiyuki Ishiba iD, Ikuno Nishibuchi iD, Fumikata Hara, Yuta Sekino, Ryunosuke Machida, Taro Shibata, Daisuke Kawahara iD, Yasuaki Sagara, Yoichi Naito iD, Kaori Terata, Yukinori Ozaki iD und 9 weitere

Japanese Journal of Clinical Oncology · 2026

DOI: 10.1093/jjco/hyag019 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Japanese Journal of Clinical Oncology, 2026. Verfasst von Keita Sasaki und 20 weiteren Autor:innen. Beteiligte Einrichtung: National Cancer Center Hospital, Japan Clinical Oncology Group Data Center/Operations Office, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit nennt 34 Literaturangaben. Gefördert von: National Cancer Center Research and Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oligometastasis is a concept that refers to the condition between localized cancer and widespread distant metastases; however, a consensus on the definition has yet to be reached. Metastasis-directed therapy (MDT) has recently been established to incorporate local therapy, such as radiotherapy and surgery, for distant metastases. Previous trials have proposed the possibility of long-term survival with the administration of MDT for patients with oligometastases. However, the efficacy and safety of MDT have not been sufficiently validated. We are conducting this clinical trial to confirm the superiority of MDT combined with subtype-specific systemic drug therapy over systemic drug therapy alone in patients with oligometastatic breast cancer. Here, “oligometastases” are defined as tumors with a maximum diameter ≤ 3 cm and total number ≤ 3. The primary endpoint is overall survival. We intend to enroll 340 patients from 62 institutions over a 3-year period. This trial has been registered in the Japan Registry of Clinical Trials (jRCTs031230439).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleNeoplasm MetastasisRandomized Controlled Trials as TopicCombined Modality Therapy

Stichwörter der Autor:innen

metastasis-directed therapyoligometastatic breast cancerradiotherapyrandomized controlled trialsurgery

Autor:innen und Institutionen

  • National Cancer Center Hospital, Japan Clinical Oncology Group Data Center/Operations Office, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Department of Breast Surgery, Institute of Science Tokyo Hospital, 1-5-45 Yushima, Bunkyo-ku, 113-8519, Tokyo, Japan.
  • Department of Radiation Oncology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
  • Department of Breast Oncology, Aichi Cancer Center, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.
  • Department of Breast Surgical Oncology, Hakuaikai Social Corporation, Sagara Hospital, 3-31 Matsubara-cho, Kagoshima-shi, Kagoshima, 892-0833, Japan.
  • Department of General Internal Medicine, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa-shi, Chiba, 277-8577, Japan.

ORCID-Profile: Keita Sasaki, Toshiyuki Ishiba, Ikuno Nishibuchi, Daisuke Kawahara, Yoichi Naito, Yukinori Ozaki, Akihiko Shimomura, Hideo Shigematsu, Kazuki Sudo, Takashi Mizowaki, Tadahiko Shien

Förderung

  • National Cancer Center Research and Development Fund

Zitieren

APA

Sasaki, K., Ishiba, T., Nishibuchi, I., Hara, F., Sekino, Y., Machida, R., Shibata, T., Kawahara, D., Sagara, Y., Naito, Y., Terata, K., Ozaki, Y., Shimomura, A., Sakai, T., Shigematsu, H., Sudo, K., Nozawa, K., Yoshimura, M., Shikama, N., …, & Shien, T. (2026). A randomized controlled trial of metastasis-directed therapy for oligometastases in breast cancer: OLIGAMI trial (JCOG2110). Japanese Journal of Clinical Oncology. https://doi.org/10.1093/jjco/hyag019

Vancouver

Sasaki K, Ishiba T, Nishibuchi I, Hara F, Sekino Y, Machida R, et al. A randomized controlled trial of metastasis-directed therapy for oligometastases in breast cancer: OLIGAMI trial (JCOG2110). Japanese Journal of Clinical Oncology. 2026. doi:10.1093/jjco/hyag019

BibTeX
@article{Sasaki2026,
  author = {Sasaki, Keita and Ishiba, Toshiyuki and Nishibuchi, Ikuno and Hara, Fumikata and Sekino, Yuta and Machida, Ryunosuke and Shibata, Taro and Kawahara, Daisuke and Sagara, Yasuaki and Naito, Yoichi and Terata, Kaori and Ozaki, Yukinori and Shimomura, Akihiko and Sakai, Takehiko and Shigematsu, Hideo and Sudo, Kazuki and Nozawa, Kazuki and Yoshimura, Michio and Shikama, Naoto and Mizowaki, Takashi and Shien, Tadahiko},
  title = {A randomized controlled trial of metastasis-directed therapy for oligometastases in breast cancer: OLIGAMI trial (JCOG2110)},
  journal = {Japanese Journal of Clinical Oncology},
  year = {2026},
  doi = {10.1093/jjco/hyag019}
}
Kostenlos starten →